Status:
UNKNOWN
Dietary Intake After Laparoscopic Sleeve Gastrectomy -a 5 Year Study
Lead Sponsor:
Min-Sheng General Hospital
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Brief Summary
Weight reducing surgery is the only effective therapy for morbid obese patients. Sleeve gastrectomy is a popular choice for bariatric surgery because of less sequela. There is poor knowledge about th...
Detailed Description
Weight reducing surgery is the only effective therapy for morbid obese patients. Restrictive type surgery is safer than mal-absorptive type surgery. Laparoscopic sleeve gastrectomy is an effective sur...
Eligibility Criteria
Inclusion
- morbid obesity patients received laparoscopic sleeve gastrectomy for more then 5 years.
- BMI above 40 kg/m2 when operation. Age 18-65 years old. No major psychosis or binge eating disorder. No endocrine disease. failed to lose weight with medical therapy.
Exclusion
- current hepatitis, under steroid treatment,cancer, thyroid disease,alcoholism.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02193529
Start Date
June 1 2014
End Date
December 1 2014
Last Update
July 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weight Loss and Metabolic Surgery Center Min-Sheng General Hospital
Taoyuan District, Taoyuan, Taiwan, 330